Efficacy of Ginkgolide B in the prophylaxis of migraine with aura - PubMed
Clinical Trial
. 2009 May:30 Suppl 1:S121-4.
doi: 10.1007/s10072-009-0074-2.
Affiliations
- PMID: 19415441
- DOI: 10.1007/s10072-009-0074-2
Clinical Trial
Efficacy of Ginkgolide B in the prophylaxis of migraine with aura
Giovanni D'Andrea et al. Neurol Sci. 2009 May.
Abstract
In a multicentric, open, preliminary trial, we evaluated the use of ginkgolide B, a herbal constituent extract from Ginkgo biloba tree leaves, in the prophylactic treatment of migraine with aura (MA). Fifty women suffering from migraine with typical aura, or migraine aura without headache, diagnosed according to International Headache Society criteria, entered a six-month study. They underwent a two month run-in period free of prophylactic drugs, followed by a four month treatment period (subdivided into two bimesters, TI and TII) with a combination of 60 mg ginkgo biloba terpenes phytosome, 11 mg coenzyme Q 10, and 8.7 mg vitamin B2 (Migrasoll), administered twice daily. A detailed diary reporting neurological symptoms, duration, and frequency of MA was compiled by patients throughout the trial. The number of MA significantly decreased during treatment (from 3.7 +/- 2.2 in the run-in period, to 2.0 +/- 1.9 during TI and to 1.2 +/- 1.6 during TII; Anova for repeated measures: P < 0.0001). There was also a statistically significant decrease in the average MA duration, which was 40.4 +/- 19.4 min during run-in, 28.2 +/- 19.9 during TI, and 17.6 +/- 20.6 during TII. Total disappearance of MA was observed in 11.1% patients during TI and in 42.2% of patients during T2. No serious adverse event was provoked by Migrasoll administration. Ginkgolide B is effective in reducing MA frequency and duration. The effect is clearly evident in the first bimester of treatment and is further enhanced during the second.
Similar articles
-
The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial.
Allais G, D'Andrea G, Maggio M, Benedetto C. Allais G, et al. Neurol Sci. 2013 May;34 Suppl 1:S161-3. doi: 10.1007/s10072-013-1413-x. Neurol Sci. 2013. PMID: 23695070 Clinical Trial.
-
Picotamide in migraine aura prevention: a pilot study.
Allais G, D'Andrea G, Airola G, De Lorenzo C, Mana O, Benedetto C. Allais G, et al. Neurol Sci. 2004 Oct;25 Suppl 3:S267-9. doi: 10.1007/s10072-004-0304-6. Neurol Sci. 2004. PMID: 15549555 Clinical Trial.
-
Esposito M, Carotenuto M. Esposito M, et al. Neurol Sci. 2011 Feb;32(1):79-81. doi: 10.1007/s10072-010-0411-5. Epub 2010 Sep 25. Neurol Sci. 2011. PMID: 20872034 Clinical Trial.
-
Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.
Orr SL, Venkateswaran S. Orr SL, et al. Cephalalgia. 2014 Jul;34(8):568-83. doi: 10.1177/0333102413519512. Epub 2014 Jan 17. Cephalalgia. 2014. PMID: 24443395 Review.
-
Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
Shi YJ, Lv J, Han XT, Luo GG. Shi YJ, et al. BMC Cardiovasc Disord. 2017 Jul 26;17(1):203. doi: 10.1186/s12872-017-0644-9. BMC Cardiovasc Disord. 2017. PMID: 28747203 Free PMC article. Review.
Cited by
-
Carotenuto M, Esposito M. Carotenuto M, et al. Neurol Sci. 2013 Nov;34(11):1905-9. doi: 10.1007/s10072-013-1403-z. Epub 2013 Mar 27. Neurol Sci. 2013. PMID: 23532548
-
Esposito M, Ruberto M, Pascotto A, Carotenuto M. Esposito M, et al. Neurol Sci. 2012 Dec;33(6):1365-8. doi: 10.1007/s10072-012-1019-8. Epub 2012 Mar 23. Neurol Sci. 2012. PMID: 22437495
-
Migraine with aura: conventional and non-conventional treatments.
D'Andrea G, Colavito D, Dalle Carbonare M, Leon A. D'Andrea G, et al. Neurol Sci. 2011 May;32 Suppl 1:S121-9. doi: 10.1007/s10072-011-0529-0. Neurol Sci. 2011. PMID: 21533727 Review.
-
Usefulness of nutraceuticals in migraine prophylaxis.
D'Onofrio F, Raimo S, Spitaleri D, Casucci G, Bussone G. D'Onofrio F, et al. Neurol Sci. 2017 May;38(Suppl 1):117-120. doi: 10.1007/s10072-017-2901-1. Neurol Sci. 2017. PMID: 28527067 Review.
-
Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature.
Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, Gangadharappa HV, Pardakhty A, Mehrbani M, Dell'Agli M, Nematollahi MH. Barani M, et al. Int J Nanomedicine. 2021 Oct 15;16:6983-7022. doi: 10.2147/IJN.S318416. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34703224 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous